Supplementary Figure 1 from Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.0
Chilam Chan, Marco Jansen, Ilona S.T. Hendriks, Ida C. van der Peet et autres
0 citations
Maaike Nederend
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
91Publications signalées
1268Citations signalées
0Affiliations récentes
Les domaines associés
Monoclonal and Polyclonal Antibodies ResearchHER2/EGFR in Cancer ResearchGlycosylation and Glycoproteins ResearchImmunodeficiency and Autoimmune DisordersCytokine Signaling Pathways and Interactions
Les publications récentes
Supplementary Figure 6 from Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.0
Chilam Chan, Marco Jansen, Ilona S.T. Hendriks, Ida C. van der Peet et autres
0 citations
Supplementary Figure 3 from Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.0
Chilam Chan, Marco Jansen, Ilona S.T. Hendriks, Ida C. van der Peet et autres
0 citations
Supplementary Figure 2 from Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.0
Chilam Chan, Marco Jansen, Ilona S.T. Hendriks, Ida C. van der Peet et autres
0 citations
Supplementary Figure 8 from Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.0
Chilam Chan, Marco Jansen, Ilona S.T. Hendriks, Ida C. van der Peet et autres
0 citations
Supplementary Figure 7 from Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.0
Chilam Chan, Marco Jansen, Ilona S.T. Hendriks, Ida C. van der Peet et autres
0 citations
Supplementary Figure 5 from Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.0
Chilam Chan, Marco Jansen, Ilona S.T. Hendriks, Ida C. van der Peet et autres
0 citations
Supplementary Figure 4 from Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.0
Chilam Chan, Marco Jansen, Ilona S.T. Hendriks, Ida C. van der Peet et autres
0 citations
Preclinical assessment of two FcγRI-specific antibodies that competitively inhibit immune complex-FcγRI binding to suppress autoimmune responses
Tosca Holtrop, Arianne M. Brandsma, L.J. Feitsma, Steffen Krohn et autres
nl, de (code pays fourni par la source)
3 citations
Nature Communications
Treatment of colorectal peritoneal metastases with oxaliplatin induces biomarkers predicting response to immune checkpoint blockade
Alexander Constantinides, Nico Lansu, Peter Mosen, Paulien Rauwerdink et autres
nl (code pays fourni par la source)
5 citations
Translational Oncology
Development and validation of a high throughput multiplex immunofluorescence assay to detect all human immunoglobulin isotypes and subclasses in human fluids
Arthur H. van Stigt, Maaike Nederend, Gaby Smits, Marjan Kuijer et autres
nl (code pays fourni par la source)
0 citations
The Journal of Immunology
The relevance of tumor target expression levels on IgA-mediated cytotoxicity in cancer immunotherapy
Chilam Chan, Núria Casalé Cabanes, J.H. Marco Jansen, Joël Guillaume et autres
de, nl (code pays fourni par la source)
8 citations
Cancer Immunology Immunotherapy
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.